Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful ...

New York City, NY, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Enjoying online casino games in the United Kingdom without spending a single pound has never been easier. The growing Free Spins No Deposit UK ...

Introduction The aetiology of eating disorders (EDs) is complex, involving an interplay of genetic and environmental factors.